HCA Healthcare’s (HCA) “Maintains” Rating Reaffirmed at Raymond James

HCA Healthcare (NYSE:HCAGet Rating)‘s stock had its “maintains” rating restated by research analysts at Raymond James in a research note issued to investors on Tuesday, Benzinga reports.

HCA has been the topic of a number of other reports. Citigroup dropped their target price on shares of HCA Healthcare from $254.00 to $240.00 in a report on Tuesday. The Goldman Sachs Group dropped their target price on shares of HCA Healthcare from $270.00 to $233.00 and set a “buy” rating on the stock in a report on Tuesday, July 12th. UBS Group increased their target price on shares of HCA Healthcare to $227.00 in a research report on Tuesday. Mizuho decreased their target price on shares of HCA Healthcare from $260.00 to $210.00 and set a “buy” rating for the company in a research report on Friday, July 1st. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of HCA Healthcare from $306.00 to $200.00 and set a “buy” rating for the company in a research report on Thursday, July 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $235.68.

HCA Healthcare Price Performance

Shares of HCA traded up $4.57 during trading hours on Tuesday, reaching $209.23. 14,726 shares of the company traded hands, compared to its average volume of 1,886,635. The stock has a fifty day simple moving average of $187.92 and a 200 day simple moving average of $225.16. HCA Healthcare has a fifty-two week low of $164.47 and a fifty-two week high of $279.02. The stock has a market capitalization of $61.82 billion, a PE ratio of 10.01, a price-to-earnings-growth ratio of 1.47 and a beta of 1.65. The company has a quick ratio of 1.32, a current ratio of 1.55 and a debt-to-equity ratio of 87.46.

HCA Healthcare (NYSE:HCAGet Rating) last announced its earnings results on Friday, July 22nd. The company reported $4.21 EPS for the quarter, beating the consensus estimate of $3.78 by $0.43. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The business had revenue of $14.82 billion for the quarter, compared to the consensus estimate of $14.73 billion. During the same period last year, the business posted $4.37 EPS. The company’s revenue was up 2.7% on a year-over-year basis. As a group, research analysts predict that HCA Healthcare will post 16.54 EPS for the current fiscal year.

Insider Transactions at HCA Healthcare

In related news, major shareholder Thomas F. Frist, Jr. purchased 89,100 shares of HCA Healthcare stock in a transaction dated Monday, May 2nd. The stock was acquired at an average cost of $211.93 per share, with a total value of $18,882,963.00. Following the completion of the transaction, the insider now directly owns 478,955 shares of the company’s stock, valued at $101,504,933.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, major shareholder Patricia F. Elcan acquired 325 shares of the stock in a transaction dated Monday, July 25th. The shares were acquired at an average price of $198.66 per share, for a total transaction of $64,564.50. Following the completion of the purchase, the insider now owns 89,337 shares in the company, valued at approximately $17,747,688.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Thomas F. Frist, Jr. purchased 89,100 shares of the firm’s stock in a transaction on Monday, May 2nd. The shares were acquired at an average price of $211.93 per share, for a total transaction of $18,882,963.00. Following the purchase, the insider now directly owns 478,955 shares of the company’s stock, valued at $101,504,933.15. The disclosure for this purchase can be found here. Insiders purchased 90,535 shares of company stock valued at $19,190,129 over the last three months. 1.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On HCA Healthcare

A number of institutional investors have recently bought and sold shares of the business. Cahaba Wealth Management Inc. lifted its holdings in shares of HCA Healthcare by 0.6% during the fourth quarter. Cahaba Wealth Management Inc. now owns 7,040 shares of the company’s stock valued at $1,809,000 after acquiring an additional 43 shares during the period. Ellevest Inc. lifted its holdings in shares of HCA Healthcare by 33.6% during the first quarter. Ellevest Inc. now owns 187 shares of the company’s stock valued at $47,000 after acquiring an additional 47 shares during the period. Veriti Management LLC lifted its holdings in shares of HCA Healthcare by 4.0% during the first quarter. Veriti Management LLC now owns 1,297 shares of the company’s stock valued at $325,000 after acquiring an additional 50 shares during the period. Oliver Luxxe Assets LLC raised its holdings in shares of HCA Healthcare by 0.4% in the fourth quarter. Oliver Luxxe Assets LLC now owns 13,470 shares of the company’s stock valued at $3,461,000 after buying an additional 51 shares during the last quarter. Finally, Highland Private Wealth Management raised its holdings in shares of HCA Healthcare by 6.4% in the first quarter. Highland Private Wealth Management now owns 876 shares of the company’s stock valued at $220,000 after buying an additional 53 shares during the last quarter. Institutional investors and hedge funds own 67.87% of the company’s stock.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.